newsfilter
← Latest News
Business Wire·

CytRx Partners with Oncology Development Expert to Advance LADR Platform

Company Begins Planning First-in-Human Studies of Next-Generation LADR Drugs CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announ